Florence Healthcare, the leading provider of Site Enablement Platforms for clinical trials, announced today that it has acquired VersaTrial, a cutting-edge clinical trial solutions provider.

The Oct. 2-3 hybrid workshop will bridge the gap between critical stakeholders to pinpoint today's challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.

Sustained acoustic medicine provides proven soft tissue healing via ZetrOZ's patented wearable ultrasound unit.

AVEO Vapor Devices, a pioneering manufacturer and supplier specializing in vape devices tailored for the cannabis industry, is pleased to announce the acquisition of licensing rights for two patents: US Patent No. US 9,999,254 B2 and Chinese Patent No. CN 206119181U.

Unmet Needs and Elevated Risk of Depression: The Challenges Faced by Caregivers of Noncancerous Brain Tumor Survivors

PA-based clinical technology provider assisTek has announced new features to its upcoming software release, including AI Integration, a Proprietary OS, SSO & Remote Provisioning, to add to its growing suite of eCOA & ePRO solutions.

The Parkinson's disease market is expected to grow to $12.8 billion by 2028.

CA CURE - its FY23 campaign - was the biggest in its 60-year history and will continue in the coming year.

Presentation to Focus on Estrogen Androgen Priming Protocol Improving IVF Response

Beginning in the second quarter of 2023, NIT will provide Actinium-225 in millicurie quantities, marking a significant step forward in cancer treatment

Now patients, caregivers and healthcare professionals have an easy and effective way to search and match to scleroderma clinical trials.

Sustained acoustic medicine delivered by wearable ultrasound device and topical diclofenac patch reduced patients' pain and improved clinical outcomes beyond traditional patient care.

Displayed the advantages of the sam X1 device as a faster way for patients to repair and recover from soft-tissue injuries before returning to work or play.

Dr. Claude Bouchard and Monique Chagnon pledge $1M to support postdoctoral fellows

The company plans to leverage its platform technology to improve access and quality to medical EEG testing and to enable and improve adjacent biomedical research and clinical trials.

Enhanced FDA reporting, full IQ/OQ package & incubator monitoring sensor round out Lab21 offerings

AmplifyBio is adding manufacturing services, starting with cell therapy and plasmids, to its growing capabilities to support the safe development of advanced therapies.

Yang Yang, PhD, of Purdue University is the recipient of a major 5-year grant for Personalized Treatment Development in SCN2A-Related Disorders

The $50,000 Vilcek Prizes for Creative Promise recognize rising immigrant scientists living and working in the United States whose work represents a significant contribution to their field.

The SYNGAP1 Gene: Seeking Treatments and the Genetic Link to Related Neurological Disorders

After successfully completing a project in RNA splicing in cancer this January, BioMed X and Merck continue their oncology collaboration to explore tumor immunogenicity enhancers.

The $50,000 Vilcek Prizes for Creative Promise recognize rising immigrant scientists living and working in the United States whose work represents a significant contribution to their field.

Legionnaires' disease cases have increased nearly tenfold in recent decades, leading to thousands of hospitalizations and deaths. Outbreaks are linked to Legionella, a bacteria found in potable water systems in large facilities like hospitals, multi-family buildings, resorts, and office buildings. A recently published study shows that copper-silver ionization effectively controls Legionella in building water systems to prevent Legionnaires' disease.

All-new Yunuverse cloud community capabilities, now standard on the Yunu platform, make it possible for over 1,000 on-demand specialty-trained radiologists, technologists, and study staff to be invited and instantly participate in any of the 4,000 in-flight imaging clinical trials running on the system today. Cancer centers may now extend the reach of trial programs to satellite sites and imaging centers, improving patient access to sophisticated oncology trials.

AmplifyBio builds on the T-cell immunology expertise of its South San Francisco-based team, adding technology platforms and capabilities in single-cell analysis and product assessment in the context of a tumor microenvironment.

The long-duration soft-tissue repair ultrasound device provides healthcare professionals with another proven method of accelerating and enhancing healing.

THE COVID-19 DETECTION FOUNDATION (dba VIRUFY) COVID-19 SCREENING THROUGH ARTIFICIAL INTELLIGENCE / MACHINE LEARNING TECHNOLOGY IS THE NEWEST MEMBER OF BARDA'S DIVISION OF RESEARCH, INNOVATION, AND VENTURES (DRIVe) MEDICAL COUNTERMEASURES PORTFOLIO

SportGait's BKG Gait technology out-predicts leading gait and balance assessments by orders of magnitude.

The Dan Lewis Foundation for Brain Regeneration Research (the DLF) announces the 2023 DLF Prize.